title: Dosing of Vasopressin in Critically Ill Children: Implications for Medication Safety.
authors.affiliation: Department of Pharmacy: Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy, Oklahoma City, OK; Department of Pediatrics, University of Oklahoma College of Medicine, Oklahoma City, OK.
authors.forename: Peter N
authors.initials: PN
authors.lastname: Johnson
authors.forename: Jamie L
authors.initials: JL
authors.lastname: Miller
authors.forename: Courtney
authors.initials: C
authors.lastname: Ranallo
mesh_terms: D001127:Arginine Vasopressin / Q000008:administration & dosage* / Q000009:adverse effects*; D006348:Cardiac Surgical Procedures; D005260:Female; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced*; D008297:Male; D058327:Norwood Procedures; D011182:Postoperative Care / Q000009:adverse effects* / Q000379:methods*; D011183:Postoperative Complications / Q000188:drug therapy* / Q000517:prevention & control*; D012769:Shock / Q000517:prevention & control*; D014652:Vascular Diseases / Q000188:drug therapy*; D014662:Vasoconstrictor Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D014883:Water-Electrolyte Imbalance / Q000517:prevention & control*
chemical_list: D014662:Vasoconstrictor Agents; D001127:Arginine Vasopressin